Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Human amygdala-like telencephalic organoids model stress circuitry in assembloid systems.

Cell stem cell·2026
Same author

Dysregulation of Hippo Signaling Pathway as a Convergent Mechanism Underlying Choroid Plexus Defects in Bipolar Disorder.

bioRxiv : the preprint server for biology·2026
Same author

Single-cell atlas of human lung aging identifies cell type dyssynchrony and increased transcriptional entropy.

Nature communications·2026
Same author

Brain-wide Genome Editing via STEP-RNPs for Treatment of Angelman Syndrome.

bioRxiv : the preprint server for biology·2025
Same author

KIAA0319 Plays a Critical Role in Cortical Neuronal Maturation and Synaptic Development Through a Dyslexia-Associated Gene Network.

Biological psychiatry·2025
Same author

Evaluating the Safety and Efficacy of Humacyte Acellular Tissue-Engineered Vessel in a Real-World Combat Setting: A Retrospective Observational Multicenter Study.

Military medicine·2025

Related Experiment Video

Updated: May 7, 2026

Generation and Grafting of Tissue-engineered Vessels in a Mouse Model
13:04

Generation and Grafting of Tissue-engineered Vessels in a Mouse Model

Published on: March 18, 2015

11.7K

Small-diameter vascular graft engineered using human embryonic stem cell-derived mesenchymal cells.

Sumati Sundaram1, Andreana Echter, Amogh Sivarapatna

  • 11 Department of Biomedical Engineering, Yale University , New Haven, Connecticut.

Tissue Engineering. Part A
|October 16, 2013
PubMed
Summary

Human embryonic stem cells (hESCs) can differentiate into smooth muscle cells for vascular grafts. However, further research is needed to ensure stable lineage commitment for regenerative medicine applications.

More Related Videos

Scaling of Engineered Vascular Grafts Using 3D Printed Guides and the Ring Stacking Method
09:38

Scaling of Engineered Vascular Grafts Using 3D Printed Guides and the Ring Stacking Method

Published on: March 27, 2017

8.1K
Implantation of Tissue-Engineered Vascular Graft in Mouse Carotid Artery via Cuff Technique
07:13

Implantation of Tissue-Engineered Vascular Graft in Mouse Carotid Artery via Cuff Technique

Published on: May 2, 2025

962

Related Experiment Videos

Last Updated: May 7, 2026

Generation and Grafting of Tissue-engineered Vessels in a Mouse Model
13:04

Generation and Grafting of Tissue-engineered Vessels in a Mouse Model

Published on: March 18, 2015

11.7K
Scaling of Engineered Vascular Grafts Using 3D Printed Guides and the Ring Stacking Method
09:38

Scaling of Engineered Vascular Grafts Using 3D Printed Guides and the Ring Stacking Method

Published on: March 27, 2017

8.1K
Implantation of Tissue-Engineered Vascular Graft in Mouse Carotid Artery via Cuff Technique
07:13

Implantation of Tissue-Engineered Vascular Graft in Mouse Carotid Artery via Cuff Technique

Published on: May 2, 2025

962

Area of Science:

  • Regenerative Medicine
  • Biomaterials Science
  • Stem Cell Biology

Background:

  • Small-diameter vascular graft development faces challenges in cell sourcing.
  • Human embryonic stem cells (hESCs) offer potential due to high proliferation and differentiation capacity.
  • Smooth muscle cells (SMCs) are crucial components of vascular tissue.

Purpose of the Study:

  • To evaluate the feasibility of creating small-diameter vascular constructs using hESC-derived SMCs.
  • To assess the differentiation potential of hESC-derived mesenchymal cells into SMCs.
  • To investigate the suitability of these constructs for vascular tissue engineering.

Main Methods:

  • Differentiated hESC-derived mesenchymal cells into SMCs using transforming growth factor beta.
  • Constructed human vessel walls by culturing differentiated cells in a bioreactor under pulsatile conditions for 8 weeks.
  • Performed histological analysis to assess cellularity, SMC marker expression, and lineage stability.

Main Results:

  • Confirmed differentiation into smooth muscle actin- and calponin-expressing SMCs.
  • Vessel grafts exhibited similarities to native vessel walls in cellularity and SMC marker expression.
  • Detected markers of cartilage and bone tissue, indicating potential lineage instability.

Conclusions:

  • hESCs can be differentiated into functional SMCs for vascular graft construction.
  • Vascular constructs show promise but require further investigation into stable lineage commitment.
  • More stringent analysis is necessary to ensure cell population purity during differentiation for regenerative applications.